Featured Research

from universities, journals, and other organizations

Type 2 diabetes decision support tool available

Date:
June 15, 2011
Source:
Keele University
Summary:
A new computerized prescribing decision support tool – designed to assist in the guidance for the management of type 2 diabetes in adults in primary care – is now available to UK healthcare professionals.

A new computerised prescribing decision support tool -- designed to assist in the implementation of NICE guidance1,2 for the management of type 2 diabetes in adults in primary care -- is now available free to UK healthcare professionals.

Developed at the Department of Medicines Management, Keele University, the user-friendly software delivers individualised prescribing recommendations by cross-referencing patient profiles with multiple treatment algorithms that are built upon NICE guidance. In practice, the practitioner is prompted with a series of multiple choice and closed questions enabling the tool to create an individual patient profile. The application interrogates the treatment algorithms, and generates an appropriate patient-tailored treatment recommendation. The tool also provides the rationale behind each recommendation, supporting references and related NICE guidance, important management considerations, common treatment side-effects, drug costs and associated recommendations on the management of blood pressure and lipids.

Professor Stephen Chapman, Professor of Prescribing Studies at Keele University said: "With both recent NICE guidance and the growing number of anti-diabetes agents at our disposal we anticipate that this intuitive tool will easily guide the prescriber through what may otherwise be an ever more complex evidence base."

The tool is also designed to support the consultation process through the use of a novel diabetes 'dashboard' visual aid, the incorporation of the UKPDS risk engine and a personalised patient printout summarising the consultation.

Once installed, the tool is kept up-to-date via automatic online updates.

The Type 2 Diabetes Management Decision Support Tool was developed by Medicines Management, Keele University with the support of a financial grant provided by Takeda UK Ltd. Takeda's only involvement has been financial. Takeda reviewed the tool for technical accuracy but had no editorial control. The development and content of the tool is the sole responsibility of Medicines management, Keele University.


Story Source:

The above story is based on materials provided by Keele University. Note: Materials may be edited for content and length.


Cite This Page:

Keele University. "Type 2 diabetes decision support tool available." ScienceDaily. ScienceDaily, 15 June 2011. <www.sciencedaily.com/releases/2011/06/110615120121.htm>.
Keele University. (2011, June 15). Type 2 diabetes decision support tool available. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/06/110615120121.htm
Keele University. "Type 2 diabetes decision support tool available." ScienceDaily. www.sciencedaily.com/releases/2011/06/110615120121.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins